Yes Hadrian I agree Hadrian will do very well.
Well we have no alternative but to hope this
way. Your logic is exactly that and sensible.
I would have liked Metrics ( Pharma CDMO
company ) to have received 30 times . Should
that have been the case we would have been
paid $1.5b instead of $725b.
There was also another option to raise $27.5m
Get a Loan from bank . These comments we are
debt free . Wrong ! We are paying interest on a loan
albeit low 2.5% . Yes at first glance. The truth is it
will cost us 9,6% of company. Exactly the same %
Mithra received for Nextellis. Although at $10.20
/ share. With your rear view mirror positive outlook
( which I like ) Mayne could have repaid both the
Bank Loan plus interest in 12 months thereby saving
huge 10% dilution. Other than that I am in your corner.
- Forums
- ASX - By Stock
- MYX
- Ann: Update on convertible note arrangements with Rubric Capital
MYX
mayne pharma group limited
Add to My Watchlist
2.19%
!
$4.92

Ann: Update on convertible note arrangements with Rubric Capital, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.92 |
Change
-0.110(2.19%) |
Mkt cap ! $399.7M |
Open | High | Low | Value | Volume |
$5.03 | $5.03 | $4.86 | $1.730M | 352.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $4.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.93 | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6000 | 4.870 |
2 | 10000 | 4.860 |
3 | 51300 | 4.850 |
1 | 600 | 4.840 |
2 | 2800 | 4.800 |
Price($) | Vol. | No. |
---|---|---|
4.930 | 25000 | 1 |
4.960 | 1303 | 1 |
4.980 | 1303 | 1 |
5.000 | 1303 | 1 |
5.020 | 1303 | 1 |
Last trade - 16.15pm 23/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |